Vimarsana
Biggest News Aggregation in the World

Page 4 - Patient Centered News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patient Centered. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patient Centered Today - Breaking & Trending Today

MC2 Therapeutics and Huadong Announce License, Development and Commercialization Agreement for Wynzo - Vimarsana News

MC2 Therapeutics and Huadong Announce License, Development and Commercialization Agreement for Wynzo

  COPENHAGEN, Denmark and HANGZHOU, China, August 31, 2023 / B3C newswire / -- MC2 Therapeutics, Ltd (“MC2”), a wholly owned subsidiary of MC2 Therapeutics A/S and Hangzhou Zhongmei Huadong Pharmaceutical Co (“Huadong”), a wholly owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), announced today a...

Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia - Vimarsana News

Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia

Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit tiered royalties WESTLAKE VILLAGE, Calif. and HANGZHOU, China, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, and Hangzhou Zhongmei Huadong Pharmaceutical Co, a wholly owned subsidiary of Huad

Source: yahoo.com
Arcutis and Huadong Announce Strategic Collaboration and - Vimarsana News

Arcutis and Huadong Announce Strategic Collaboration and

Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit...

ASCO 2023 to Highlight Treatment Options, Partnerships With Patients in Guiding Cancer Care - Vimarsana News

ASCO 2023 to Highlight Treatment Options, Partnerships With Patients in Guiding Cancer Care

The cancer care community descends on Chicago this weekend for the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO). This year’s theme, “Partnering With Patients: The Cornerstone of Cancer Care and Research,” highlights how recent advances make interactions between clinicians and patients more important than ever, as shared decision-making must be the foundation of the care journey.

Source: ajmc.com
Health Care Reform in Maine: Reversing "Obamacare Lite" | The Heritage Foundation - Vimarsana News

Health Care Reform in Maine: Reversing "Obamacare Lite" | The Heritage Foundation

This spring, after living under the costly failures of Obamacare-like health care legislation for two decades, the Maine Legislature enacted a set of patient-centered, market-based health care reforms. The Maine experience is both a warning of Obamacare’s likely effects and a practical demonstration to other states of how to enact sound free-market health care reforms in spite of Obamacare. Maine has also shown how much more it and other states could accomplish if not hamstrung by Obamacare and how Congress could chart a better course toward more innovative and effective health care reform.